Mary Siegel
CEO of MSIR
Replay available
Protalix BioTherapeutics, Inc. (DE) (PLX) Q3 2025 Earnings Call
Protalix BioTherapeutics, Inc. (DE) (AMEX: PLX) Q3 2025 earnings conference call, held 2025-11-13. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Gabby Weissman
President and CEO of NOVA
Guy Kisner
Chief Financial Officer of NOVA
Atif Malik
Analyst, Citi
Duxen Zhang
Analyst, Bank of America (on behalf of Vivek Arya)
Vinvati Shroche
Analyst, Evercore ISI
Matthew Presco
Analyst, Kantor
Mark Miller
Analyst, Benchmark Company
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Protalix Biotherapeutics, Inc. (de).
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:05.936 and welcome to the NOVA Limited fourth quarter and full year 2024 results 00:00:05.936 -- 00:00:10.581 conference call. All participants will be in listen-only mode. 00:00:10.581 -- 00:00:15.165 Should you need assistance, please signal a conference specialist by pressing the star 00:00:15.165 -- 00:00:17.727 key followed by zero. 00:00:17.727 -- 00:00:22.631 After today's presentation, there will be an opportunity to ask questions. 00:00:22.631 -- 00:00:27.636 To ask a question, you may press star then one on your telephone keypad. 00:00:27.636 -- 00:00:31.774 To withdraw your question, please press star, then two. 00:00:31.774 -- 00:00:35.217 Please note this event is being recorded. 00:00:35.217 -- 00:00:40.743 I would now like to turn the conference over to Mary Siegel, CEO of MSIR. 00:00:40.743 -- 00:00:42.985 Please go ahead. 00:00:42.985 -- 00:00:46.208 Thank you, operator, and good day to everybody. 00:00:46.208 -- 00:00:51.534 I would like to welcome all of you to NOVA's fourth quarter and full year 2024 00:00:51.534 -- 00:00:53.015 financial 00:00:53.015 -- 00:00:58.657 results conference call. With us on the line today are Gabby Weissman, 00:00:58.657 -- 00:01:03.923 President and CEO, and Guy Kisner, CFO. 00:01:03.923 -- 00:01:09.291 Before we begin, I would like to remind our listeners that certain information provided 00:01:09.291 -- 00:01:14.297 on this call may contain forward-looking statements, and the safe harbor 00:01:14.297 -- 00:01:19.324 statement outlined in today's earnings release also pertains 00:01:19.324 -- 00:01:24.556 to this call. If you have not received a copy of the release, Please view 00:01:24.556 -- 00:01:29.681 it in the investor relations section of the company's website. 00:01:29.681 -- 00:0...